首页> 美国卫生研究院文献>Journal of Radiation Research >Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer
【2h】

Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer

机译:乳腺癌患者放疗后骨转移灶的密度增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to assess local response to radiotherapy (RT) in a quantitative manner by evaluating the bone density of metastases. Spinal and pelvic bone metastases in 44 patients with breast cancer who were treated between May 2010 and December 2016 were retrospectively assessed. Bone density values of irradiated and unirradiated bone metastases before, 1–3 months after, 4–6 months after, and 7–9 months after RT were compared. At each time point, mean bone density ± standard deviation values were measured in Hounsfield units (HU) from computed tomography (CT) scans. Student’s t-test was used for statistical analyses of the differences in bone density and for univariate analysis of the prognostic factors for differences in bone density at various time points after RT. Mean bone densities in irradiated and unirradiated bone metastases before RT were 297.31 ± 211.93 HU and 326.29 ± 228.61 HU, respectively. At the subsequent three time points examined, the mean bone density values in the irradiated and unirradiated bone metastases were: 61.97 ± 78.58 HU (P = 0.000) and 36.93 ± 52.49 HU (P = 0.001); 149.07 ± 133.27 HU (P = 0.000) and 68.40 ± 101.10 HU (P = 0.000); and 183.94 ± 168.30 HU (P = 0.000) and 88.21 ± 159.49 HU (P = 0.004), respectively, in each case. Patients receiving bisphosphonates exhibited greater increases in bone density in their metastases 1–3 months after RT (83.04 ± 82.18 HU vs 26.86 ± 60.55 HU, respectively; P = 0.044), whereas chemotherapy before RT was associated with significantly lower increases in bone density at the subsequent three time points [(37.53 ± 67.66 HU vs 93.63 ± 80.36 HU, P = 0.027), (99.30 ± 107.92 HU vs 180.24 ± 127.85 HU, P = 0.030), and (126.07 ± 141.77 HU vs 236.28 ± 158.22 HU, P = 0.024), respectively, in each case]. Comparing bone density values determined from CT scans appears to be a practicable and reproducible method for assessing local response to RT for bone metastasis of breast cancer. Increased bone density was also observed in the irradiated bone metastases.
机译:这项研究的目的是通过评估转移瘤的骨密度,以定量方式评估对放疗(RT)的局部反应。回顾性评估2010年5月至2016年12月间接受治疗的44例乳腺癌患者的脊柱和骨盆骨转移。比较了放疗前,放疗后1-3个月,放疗后4-6个月和放疗后7-9个月的经照射和未经照射的骨转移的骨密度值。在每个时间点,通过计算机断层扫描(CT)扫描以Hounsfield单位(HU)测量平均骨密度±标准偏差值。学生的t检验用于进行骨密度差异的统计分析,并用于RT后各个时间点骨密度差异的预后因素的单变量分析。 RT照射前和未照射骨转移的平均骨密度分别为297.31±211.93 HU和326.29±228.61 HU。在随后的三个检查时间点,经辐照和未经辐照的骨转移的平均骨密度值为:61.97±78.58 HU(P = 0.000)和36.93±52.49 HU(P = 0.001); 149.07±133.27 HU(P = 0.000)和68.40±101.10 HU(P = 0.000);分别为183.94±168.30 HU(P = 0.000)和88.21±159.49 HU(P = 0.004)。接受双膦酸盐治疗的患者在放疗后1至3个月,其转移的骨密度显示出更大的增加(分别为83.04±82.18 HU和26.86±60.55 HU; P = 0.044),而放疗前的化疗与降低显着降低骨密度相关随后的三个时间点[(37.53±67.66 HU vs. 93.63±80.36 HU,P = 0.027),(99.30±107.92 HU vs 180.24±127.85 HU,P = 0.030),和(126.07±141.77 HU vs 236.28±158.22 HU, P = 0.024)。比较从CT​​扫描确定的骨密度值似乎是评估乳腺癌局部转移对RT的局部反应的可行且可重现的方法。在照射的骨转移中也观察到骨密度增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号